EM
PMC

Endicott Management’s PharMerica Corporation PMC Stock Holding History

Endicott Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,000
Closed -$449K – 43
2016
Q3 		$449K Buy
+16,000
New +$410K 0.2% 32
2016
Q2 		– Sell
-30,000
Closed -$663K – 48
2016
Q1 		$663K Buy
+30,000
New +$798K 0.23% 30

Other funds holding PMC

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Endicott Management's PMC Position: Q4 2016 in Review

Endicott Management sold out of PharMerica Corporation (PMC) in Q4 2016, closing a stake of 16,000 shares — an estimated $449K sold.

Endicott Management first reported a position in PMC in Q1 2016 and held it in 2 quarters. The position peaked at $663K in Q1 2016. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

  • Endicott Management reported no remaining PharMerica Corporation position as of Q4 2016 after selling out during the quarter.
  • Endicott Management sold 16,000 PharMerica Corporation shares in Q4 2016, an estimated $449K.
  • Endicott Management first reported a position in PharMerica Corporation in Q1 2016 and held it in 2 quarters.
  • Endicott Management's PharMerica Corporation position peaked at $663K in Q1 2016.
  • 166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on Endicott Management's 13F filing for Q4 2016, filed 14 Feb 2017.